Literature DB >> 2586951

Increased neutrophil activation in diabetic pregnancy and in nonpregnant diabetic women.

I A Greer1, N G Haddad, J Dawes, T A Johnston, F D Johnstone, J M Steel.   

Abstract

Human neutrophil elastase may be a mediator of vascular damage, and enhanced neutrophil reactivity could contribute to the susceptibility of pregnant diabetic women to vascular complications. Elevated plasma levels of neutrophil elastase will reflect neutrophil activation in vivo. The aim of this study was to determine whether neutrophil activation occurs in uncomplicated diabetic pregnancy. We studied 30 normal nonpregnant women, 20 nonpregnant diabetic women, 32 nondiabetic women with normal pregnancies, and 17 insulin-requiring pregnant diabetic patients. Plasma neutrophil elastase was measured by radioimmunoassay. There was a significantly higher concentration of plasma neutrophil elastase in normal pregnant women compared with the nonpregnant group (P less than .001). The nonpregnant diabetic group had significantly higher concentrations than the normal nonpregnant group (P less than .002). The pregnant diabetic group had significantly higher concentrations than the nonpregnant diabetic group (P less than .001) and the normal pregnant group (P less than .05). The high concentrations of plasma neutrophil elastase may contribute to the greater sensitivity of pregnant diabetic patients to vascular complications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586951

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.

Authors:  Eleazar Soto; Karina Richani; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Luis Goncalves; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

Review 2.  Neutrophils in type 1 diabetes.

Authors:  Juan Huang; Yang Xiao; Aimin Xu; Zhiguang Zhou
Journal:  J Diabetes Investig       Date:  2016-02-01       Impact factor: 4.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.